keyword
https://read.qxmd.com/read/38647433/practical-three-component-regioselective-synthesis-of-drug-like-3-aryl-or-heteroaryl-5-6-dihydrobenzo-h-cinnolines-as-potential-non-covalent-multi-targeting-inhibitors-to-combat-neurodegenerative-diseases
#1
JOURNAL ARTICLE
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
Neurodegenerative diseases (NDs) are one of the prominent health challenges facing contemporary society, and many efforts have been made to overcome and (or) control it. In this research paper, we described a practical one-pot two-step three-component reaction between 3,4-dihydronaphthalen-1(2 H )-one ( 1 ), aryl(or heteroaryl)glyoxal monohydrates ( 2a - h ), and hydrazine monohydrate (NH2 NH2 •H2 O) for the regioselective preparation of some 3-aryl(or heteroaryl)-5,6-dihydrobenzo[ h ]cinnoline derivatives ( 3a - h )...
April 22, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38628547/a-lipid-plga-nanocomplex-to-reshape-tumor-immune-microenvironment-for-colon-cancer-therapy
#2
JOURNAL ARTICLE
Nan Zhang, Qiqi Sun, Junhua Li, Jing Li, Lei Tang, Quan Zhao, Yuji Pu, Gaofeng Liang, Bin He, Wenxia Gao, Jianlin Chen
Immune checkpoint blockade therapy provides a new strategy for tumor treatment; however, the insufficient infiltration of cytotoxic T cells and immunosuppression in tumor microenvironment lead to unsatisfied effects. Herein, we reported a lipid/PLGA nanocomplex (RDCM) co-loaded with the photosensitizer Ce6 and the indoleamine 2,3-dioxygenase (IDO) inhibitor 1MT to improve immunotherapy of colon cancer. Arginine-glycine-aspartic acid (RGD) as the targeting moiety was conjugated on 1,2-distearoyl-snglycero-3-phosphoethanolamine lipid via polyethylene glycol (PEG), and programmed cell death-ligand 1 (PD-L1) peptide inhibitor DPPA (sequence: CPLGVRGK-GGG-d(NYSKPTDRQYHF)) was immobilized on the terminal group of PEG via matrix metalloproteinase 2 sensitive peptide linker...
2024: Regenerative Biomaterials
https://read.qxmd.com/read/38603953/phase-ii-trial-of-pembrolizumab-and-epacadostat-in-recurrent-clear-cell-carcinoma-of-the-ovary-an-nrg-oncology-study-gy016
#3
JOURNAL ARTICLE
Lilian T Gien, Danielle M Enserro, Matthew S Block, Steven Waggoner, Linda R Duska, Andrea E Wahner-Hendrickson, Premal H Thaker, Floor Backes, Michael Kidd, Carolyn Y Muller, Paul A DiSilvestro, Allan Covens, David M Gershenson, Kathleen N Moore, Carol Aghajanian, Robert L Coleman
INTRODUCTION: Early reports of PD-1 inhibition in ovarian clear cell carcinomas (OCCC) demonstrate promising response. We evaluated the combination of pembrolizumab and IDO-1 inhibitor epacadostat in patients with recurrent OCCC. METHODS: This single arm, two-stage, phase 2 trial included those with measurable disease and 1-3 prior regimens. Patients received intravenous pembrolizumab 200 mg every 3 weeks and oral epacadostat 100 mg twice a day. Primary endpoint was overall response rate (ORR), secondary endpoints were toxicity, progression-free survival (PFS) and overall survival (OS)...
April 10, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38583227/simultaneous-mass-spectrometric-quantification-of-trace-amines-their-precursors-and-metabolites
#4
JOURNAL ARTICLE
Krisztina de Bruyn, Eugene F Diekman, Claude P van der Ley, Martijn van Faassen, Ido P Kema
OBJECTIVES: Trace amines are powerful neuromodulators influencing the release and reuptake of catecholamines. These low concentrated endogenous amines impact mood, cognition, and hormone regulation. Dysregulation of trace amines have been associated with a variety of diseases, such as schizophrenia, Parkinson's disease, migraine, depression and more. Succesfull simultaneous quantification of trace amines, their precursors and metabolites would benefit both research and patient care. Since these compounds have various functional groups and are present in biological matrices with large concentration difference, their simultaneous quantification is an analytical challenge...
March 18, 2024: Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
https://read.qxmd.com/read/38513170/plasma-proteome-based-test-for-first-line-treatment-selection-in-metastatic-non-small-cell-lung-cancer
#5
JOURNAL ARTICLE
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner-Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
PURPOSE: Current guidelines for the management of metastatic non-small cell lung cancer (NSCLC) without driver mutations recommend checkpoint immunotherapy with PD-1/PD-L1 inhibitors, either alone or in combination with chemotherapy. This approach fails to account for individual patient variability and host immune factors and often results in less-than-ideal outcomes. To address the limitations of the current guidelines, we developed and subsequently blindly validated a machine learning algorithm using pretreatment plasma proteomic profiles for personalized treatment decisions...
March 2024: JCO Precision Oncology
https://read.qxmd.com/read/38487531/biological-insights-from-plasma-proteomics-of-non-small-cell-lung-cancer-patients-treated-with-immunotherapy
#6
JOURNAL ARTICLE
Jair Bar, Raya Leibowitz, Niels Reinmuth, Astrid Ammendola, Eyal Jacob, Mor Moskovitz, Adva Levy-Barda, Michal Lotem, Rivka Katsenelson, Abed Agbarya, Mahmoud Abu-Amna, Maya Gottfried, Tatiana Harkovsky, Ido Wolf, Ella Tepper, Gil Loewenthal, Ben Yellin, Yehuda Brody, Nili Dahan, Maya Yanko, Coren Lahav, Michal Harel, Shani Raveh Shoval, Yehonatan Elon, Itamar Sela, Adam P Dicker, Yuval Shaked
INTRODUCTION: Immune checkpoint inhibitors have made a paradigm shift in the treatment of non-small cell lung cancer (NSCLC). However, clinical response varies widely and robust predictive biomarkers for patient stratification are lacking. Here, we characterize early on-treatment proteomic changes in blood plasma to gain a better understanding of treatment response and resistance. METHODS: Pre-treatment (T0) and on-treatment (T1) plasma samples were collected from 225 NSCLC patients receiving PD-1/PD-L1 inhibitor-based regimens...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38482400/non-targeted-metabolomics-analysis-of-indoleamine-2-3-dioxygenase-inhibitor-treatment-in-a-mouse-model-of-early-stage-lung-adenocarcinoma
#7
JOURNAL ARTICLE
Meixiang Xu, Jiayang Chen, Chaoyang Peng, Liang Mo
BACKGROUND: Lung adenocarcinoma is a common malignant tumor, and its early diagnosis and treatment are key to improving patient survival rates. However, due to the non-specific early symptoms, many patients are already at an advanced stage when diagnosed. Non-targeted metabolomics analysis, as a method for comprehensive analysis of metabolites in the body, has been shown to have potential in the early diagnosis of cancer. This study aims to identify early-stage lung adenocarcinoma-specific biomarkers using non-targeted metabolomics analysis in an established mouse model...
February 29, 2024: Translational Cancer Research
https://read.qxmd.com/read/38458463/macrophage-ahr-tlr4-cross-talk-drives-p-stat3-ser727-mediated-mitochondrial-oxidative-stress-and-upregulates-ido-icam-1-in-the-steatohepatitis-induced-by-aflatoxin-b-1
#8
JOURNAL ARTICLE
Jing Zhang, Hui Liu, Yang Shen, Dong Cheng, Hui Tang, Qi Zhang, Chao Li, Ming Liu, Wenhuan Yao, Rongrong Ran, Qingzhen Hou, Xiulan Zhao, Jia-Sheng Wang, Xiulan Sun, Tianliang Zhang, Jun Zhou
Aflatoxin B1 (AFB1 ) is a major mycotoxin contaminant showing in the environment and foods. In this study, the molecular initiating events (MIEs) of AFB1 -induced steatohepatitis were explored in mice and human cell model. We observed dose-dependent steatohepatitis in the AFB1 -treated mice, including triglyceride accumulation, fibrotic collagen secretion, enrichment of CD11b + and F4/80+ macrophages/Kupffer cells, cell death, lymphocytes clusters and remarkable atrophy areas. The gut barrier and gut-microbiota were also severely damaged after the AFB1 treatment and pre-conditioned colitis in the experimental mice aggravated the steatohepatitis phenotypes...
March 6, 2024: Science of the Total Environment
https://read.qxmd.com/read/38451784/targeting-tryptophan-catabolism-in-ovarian-cancer-to-attenuate-macrophage-infiltration-and-pd-l1-expression
#9
JOURNAL ARTICLE
Lyndsey S Crump, Jessica L Floyd, Li-Wei Kuo, Miriam D Post, Mike Bickerdike, Kathleen O'Neill, Kayla Sompel, Kimberly R Jordan, Bradley R Corr, Nicole Marjon, Elizabeth R Woodruff, Jennifer K Richer, Benjamin G Bitler
High grade serous carcinoma (HGSC) of the fallopian tube, ovary and peritoneum is the most common type of ovarian cancer and is predicted to be immunogenic since the presence of tumor-infiltrating lymphocytes conveys a better prognosis. However, the efficacy of immunotherapies has been limited due to the immune-suppressed tumor microenvironment (TME). Tumor metabolism and immune-suppressive metabolites directly affect immune cell function through the depletion of nutrients and activation of immune-suppressive transcriptional programs...
March 7, 2024: Cancer Res Commun
https://read.qxmd.com/read/38385162/the-biotherapeutic-clostridium-butyricum-miyairi-588-strain-potentiates-enterotropism-of-ror%C3%AE-t-treg-and-pd-1-blockade-efficacy
#10
JOURNAL ARTICLE
Thomas Paz Del Socorro, Kentaro Oka, Olivier Boulard, Motomichi Takahashi, Lionel Franz Poulin, Atsushi Hayashi, Mathias Chamaillard
Immune checkpoint inhibitors (ICI) have been positioned as a standard of care for patients with advanced non-small-cell lung carcinomas (NSCLC). A pilot clinical trial has reflected optimistic association between supplementation with Clostridium butyricum MIYAIRI 588 (CBM588) and ICI efficacy in NSCLC. However, it remains to be established whether this biotherapeutic strain may be sufficient to heighten the immunogenicity of the tumor draining lymph nodes to overcome resistance to ICI. Herein, we report that supplementation with CBM588 led to an improved responsiveness to antibody targeting programmed cell death protein 1 (aPD-1)...
2024: Gut Microbes
https://read.qxmd.com/read/38367683/a-peripheral-blood-mononuclear-cell-based-in-vitro-model-a-tool-to-explore-indoleamine-2-3-dioxygenase-1-ido1
#11
JOURNAL ARTICLE
Milene Gonçalves, Alessia Furgiuele, Emanuela Rasini, Massimiliano Legnaro, Marco Ferrari, Alessandra Luini, Paulo Rodrigues-Santos, Francisco Caramelo, Franca Marino, Frederico C Pereira, Marco Cosentino
BACKGROUND: Proinflammatory cytokines powerfully induce the rate-limiting enzyme indoleamine 2, 3-dioxygenase-1 (IDO-1) in dendritic cells (DCs) and monocytes, it converts tryptophan (Trp) into L-kynurenine (KYN), along the kynurenine pathway (KP). This mechanism represents a crucial innate immunity regulator that can modulate T cells. This work explores the role of IDO1 in lymphocyte proliferation within a specific pro-inflammatory milieu. METHODS: PBMCs were isolated from buffy coats taken from healthy blood donors and exposed to a pro-inflammatory milieu triggered by a double-hit stimulus: lipopolysaccharide (LPS) plus anti-CD3/CD28...
February 15, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38354557/a-metal-organic-framework-mof-built-on-surface-modified-cu-nanoparticles-eliminates-tumors-via-multiple-cascading-synergistic-therapeutic-effects
#12
JOURNAL ARTICLE
Guanghui An, Heming Zheng, Lianshan Guo, Jingmei Huang, Congling Yang, Zhihao Bai, Nannan Wang, Wenhui Yang, Yanqiu Zhu
Tumors produce a hypoxic environment that greatly influences cancer treatment, and conventional chemotherapeutic drugs cannot selectively accumulate in the tumor region because of the lack of a tumor targeting mechanism, causing increased systemic toxicities and side effects. Hence, designing and developing new nanoplatforms that combine multimodal therapeutic regimens is essential to improve tumor therapeutic efficacy. Herein, we report the synthesis of ultrafine Cu nanoparticles loaded with a drug combination of cisplatin (Pt) and 1-methyl-d-tryptophan (1-MT) and externally coated with 5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin (TCPP) photosensitizer, polydopamine (PDA) and CaO2 of MIL-101(Fe) as a new nanoplatform (Cu@MIL-101@PMTPC)...
February 9, 2024: Journal of Colloid and Interface Science
https://read.qxmd.com/read/38328710/reversal-of-the-immunosuppressive-tumor-microenvironment-via-platinum-based-neoadjuvant-chemotherapy-in-cervical-cancer
#13
JOURNAL ARTICLE
Xue Feng, Xiaolin Meng, Dihong Tang, Shuaiqingying Guo, Qiuyue Liao, Jing Chen, Qin Xie, Fengyuan Liu, Yong Fang, Chaoyang Sun, Yingyan Han, Jihui Ai, Kezhen Li
BACKGROUND: Immunotherapy favors patients with tumors; however, only 3-26.3% of patients with cervical cancer benefit from single-agent immune checkpoint inhibitors. Combined immunotherapy and chemotherapy has been explored against tumor; however, the combination remains controversial. This study aimed to investigate the tumor immune microenvironment (TIME) and the effects of platinum-based neoadjuvant chemotherapy (NACT) in cervical cancer to identify the clinical value of combining chemotherapy with immunotherapy...
January 2024: Cancer Pathog Ther
https://read.qxmd.com/read/38268530/alleviation-of-rheumatoid-arthritis-by-inducing-ido-expression-with-trichinella-spiralis-recombinant-protein-43
#14
JOURNAL ARTICLE
Xiao Ma, Dongming Liu, Wenhao Yu, Caixia Han
Rheumatoid arthritis (RA) represents the autoimmune disorder that shows aggressive arthritis as the main symptom. It is difficult to treat and can lead to joint deformation and function loss. At present, Trichinella spiralis ( T. spiralis ) antigen has attracted much attention because it plays a role in host immune regulatory mechanisms. Therefore, we selected T. spiralis recombinant protein 43 (Tsp43) to treat the bovine collagen type II (BCII)-induced mice RA model and explored its therapeutic mechanisms...
2024: Journal of Immunology Research
https://read.qxmd.com/read/38260240/efficacy-and-mechanism-of-a-biomimetic-nanosystem-carrying-doxorubicin-and-an-ido-inhibitor-for-treatment-of-advanced-triple-negative-breast-cancer
#15
JOURNAL ARTICLE
Chuling Hu, Yan Liu, Wei Cao, Na Li, Shen Gao, Zhuo Wang, Fenfen Gu
INTRODUCTION: Chemotherapy is still the treatment of choice for advanced triple-negative breast cancer. Chemotherapy combined with immunotherapy is being tried in patients with triple-negative breast cancer. As a kind of "cold tumor", triple-negative breast cancer has a bottleneck in immunotherapy. Indoleamine 2, 3-dioxygenase-1 inhibitors can reverse the immunosuppressive state and enhance the immune response. METHODS: In this study, mesoporous silica nanoparticles were coated with the chemotherapeutic drug doxorubicin and indoleamine 2, 3-dioxygenase 1 inhibitor 1-Methyl-DL-tryptophan (1-MT), and then encapsulate the surfaces of a triple-negative breast cancer cell membrane to construct the tumor dual-targeted delivery system CDIMSN for chemotherapy and immunotherapy, and to investigate the immunogenic death effect of CDIMSN...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38242547/medical-cannabis-and-its-effect-on-oncological-outcomes-in-patients-with-ovarian-cancer-treated-with-parp-inhibitors
#16
JOURNAL ARTICLE
Shira Peleg Hasson, Eliya Shachar, Miriam R Brezis, Akram Saad, Bar Toledano, Nadav Michaan, Ido Laskov, Dan Grisaru, Jeffrey Goldstein, Amir Nutman, Tamar Safra
BACKGROUND: Poly (ADP-ribose) polymerase inhibitors (PARPi) play a pivotal role in ovarian cancer management. With medical cannabis emerging as a novel component of supportive care, this study investigated the impact of medical cannabis use on oncological outcomes in patients with ovarian cancer undergoing PARPi therapy. METHODS: The study included patients from a single institution database treated for ovarian cancer between January 2014 and January 2020 who received PARPi maintenance therapy in a first-line or recurrent disease setting after a confirmed response to platinum-based treatment...
January 19, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38241676/n1-acetyl-5-methoxykynuramine-which-decreases-in-the-hippocampus-with-aging-improves-long-term-memory-via-camkii-creb-phosphorylation
#17
JOURNAL ARTICLE
Kazuki Watanabe, Yusuke Maruyama, Hikaru Iwashita, Haruyasu Kato, Jun Hirayama, Atsuhiko Hattori
Melatonin is a molecule ubiquitous in nature and involved in several physiological functions. In the brain, melatonin is converted to N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and then to N1-acetyl-5-methoxykynuramine (AMK), which has been reported to strongly enhance long-term object memory formation. However, the synthesis of AMK in brain tissues and the underlying mechanisms regarding memory formation remain largely unknown. In the present study, young and old individuals from a melatonin-producing strain, C3H/He mice, were employed...
January 2024: Journal of Pineal Research
https://read.qxmd.com/read/38229073/comprehensive-genomic-evaluation-of-advanced-and-recurrent-breast-cancer-patients-for-tailored-precision-treatments
#18
JOURNAL ARTICLE
Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Nakano
AIM: The aim of this study was to investigate genetic alterations within breast cancer in the setting of recurrent or de novo stage IV disease. PATIENTS AND METHODS: This study included 22 patients with recurrent breast cancer (n = 19) and inoperable de novo stage IV breast cancer (n = 3). For next generation sequencing, FoundationOneCDx (F1CDx) (Foundation Medicine Inc., Cambridge, MA, USA) was performed in 21 patients and FoundationOneLiquid CDx was performed in 1 patient...
January 16, 2024: BMC Cancer
https://read.qxmd.com/read/38212825/sodium-glucose-co-transporter-2-inhibitors-in-patients-treated-with-immune-checkpoint-inhibitors
#19
JOURNAL ARTICLE
Moran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, Yasmin Leshem, Or Bainhoren, Tammi Arbel Rubinstein, Maxim Perelman, Zach Rozenbaum, Ofer Havakuk, Yan Topilsky, Shmuel Banai, Ido Wolf, Michal Laufer-Perl
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the prognosis of cancer. Diabetes mellitus (DM) has been shown to have a negative effect on patients treated with ICIs. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are effective antidiabetic therapies associated with reduced all-cause mortality and cardiovascular (CV) outcomes. OBJECTIVE: To evaluate the prognostic value of SGLT2i on all-cause mortality and cardiotoxicity among patients treated with ICIs...
January 11, 2024: Cardio-Oncology
https://read.qxmd.com/read/38203646/role-of-tgf-%C3%AE-and-p38-mapk-in-tsg-6-expression-in-adipose-tissue-derived-stem-cells-in-vitro-and-in-vivo
#20
JOURNAL ARTICLE
Hye Youn Kwon, Yongdae Yoon, Ju-Eun Hong, Ki-Jong Rhee, Joon Hyung Sohn, Pil Young Jung, Moon Young Kim, Soon Koo Baik, Hoon Ryu, Young Woo Eom
Mesenchymal stem cells (MSCs) regulate immune cell activity by expressing tumor necrosis factor-α (TNF-α)-stimulated gene 6 (TSG-6) in inflammatory environments; however, whether anti-inflammatory responses affect TSG-6 expression in MSCs is not well understood. Therefore, we investigated whether transforming growth factor-β (TGF-β) regulates TSG-6 expression in adipose tissue-derived stem cells (ASCs) and whether effective immunosuppression can be achieved using ASCs and TGF-β signaling inhibitor A83-01...
December 29, 2023: International Journal of Molecular Sciences
keyword
keyword
161144
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.